SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
SGNT was delisted on the 29th of August, 2016.
131 hedge funds and large institutions have $614M invested in SAGENT PHARMACEUTICALS INC COM STK (DE) in 2014 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 57 increasing their positions, 30 reducing their positions, and 10 closing their positions.
200% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 10
90% more repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 30
15% more funds holding
Funds holding: 114 → 131 (+17)
16% less capital invested
Capital invested by funds: $734M → $614M (-$119M)
100% less call options, than puts
Call options by funds: $4K | Put options by funds: $1.26M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
+$19.4M |
| 2 |
RIM
Ranger Investment Management
Dallas,
Texas
|
+$7.44M |
| 3 |
State Street
Boston,
Massachusetts
|
+$5.56M |
| 4 |
Millennium Management
New York
|
+$4.87M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$4.78M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$37.4M |
| 2 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$9.36M |
| 3 |
PCM
Penn Capital Management
Philadelphia,
Pennsylvania
|
-$7.77M |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$5.74M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$4.8M |
SGNT Hedge Fund Activity: Q4 2014 in Review
131 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) for Q4 2014, worth a combined $614M — down 16% from $734M a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new SGNT positions and 10 closed out — a net gain of 20 holders — while 57 added to existing stakes and 30 trimmed.
The largest buyer was Acadian Asset Management, adding an estimated $19.4M. The largest seller was Franklin Resources, cutting an estimated $37.4M.
- 131 institutional investors held SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) as of Q4 2014, up from 114 in Q3 2014.
- Funds reported $614M of SAGENT PHARMACEUTICALS INC COM STK (DE) stock for Q4 2014, down 16% quarter-over-quarter.
- 30 funds opened new SAGENT PHARMACEUTICALS INC COM STK (DE) positions in Q4 2014 and 10 closed out, a net change of +20 holders.
- The largest SAGENT PHARMACEUTICALS INC COM STK (DE) buyer in Q4 2014 was Acadian Asset Management, an estimated $19.4M added.
- The largest SAGENT PHARMACEUTICALS INC COM STK (DE) seller in Q4 2014 was Franklin Resources, an estimated $37.4M sold.
Based on aggregated 13F filings for Q4 2014.